MIC Capital Management UK LLP holds a concentrated book of 16 stocks worth $394.3M as of Q2 2026 (disclosed Aug 10, 2026, a ~41-day 13F lag). This quarter they opened Alibaba Group Holding-SP ADR and trimmed Hayward Holdings Inc. Their largest long position is Hayward Holdings Inc at 27% of the equity book.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as MIC Capital Management UK LLP
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| BlackRock, Inc. | 18 / 16 | $113.1B |
| JPMORGAN CHASE & CO | 18 / 16 | $34.0B |
| MORGAN STANLEY | 18 / 16 | $26.9B |
| BANK OF AMERICA CORP /DE/ | 18 / 16 | $14.9B |
| GOLDMAN SACHS GROUP INC | 18 / 16 | $14.3B |
| UBS Group AG | 18 / 16 | $8.2B |
| ROYAL BANK OF CANADA | 18 / 16 | $7.5B |
| WELLS FARGO & COMPANY/MN | 18 / 16 | $6.1B |
Ranked by how many of MIC Capital Management UK LLP's top 16 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Hayward Hldgs Inc COM | $106.8M | 6.17M | 27.1% | ▼−6.1% Reduced · −401K sh | |
| 2 | Revolution Medicines Inc COM | $99.6M | 531.7K | 25.3% | ▼−33% Reduced · −264K sh | |
| 3 | Recursion Pharmaceuticals In CL A | $35.4M | 9.64M | 9.0% | ▲~0% Added · +1 sh | |
| 4 | Restaurant Brands Intl Inc COM | $28.0M | 386.2K | 7.1% | —Held | |
| 5 | Coupang Inc CL A | $24.5M | 1.41M | 6.2% | —Held | |
| 6 | Grab Holdings Limited CLASS A ORD | $18.9M | 5.00M | 4.8% | —Held | |
| 7 | Meta Platforms Inc CL A | $18.8M | 33.3K | 4.8% | —Held | |
| 8 | Klarna Group PLC SHS | $17.3M | 852.5K | 4.4% | ▼−69% Reduced · −1.9M sh | |
| 9 | Alibaba Group Hldg Ltd SPONSORED ADS | $14.4M | 150.0K | 3.7% | ▲New New position | |
| 10 | Capital One Finl Corp COM | $9.6M | 48.0K | 2.4% | ▲New New position | |
| 11 | Neumora Therapeutics Inc. COM | $7.6M | 4.46M | 1.9% | —Held | |
| 12 | Monday Com Ltd SHS | $4.8M | 66.0K | 1.2% | —Held | |
| 13 | Rocket Lab Corp COM | $3.6M | 35.6K | 0.9% | —Held | |
| 14 | Archer Aviation Inc COM CL A | $3.3M | 700.0K | 0.8% | —Held | |
| 15 | Lyell Immunopharma Inc COM NEW | $1.2M | 87.0K | 0.3% | —Held | |
| 16 | Billiontoone Inc CL A | $587K | 4.9K | 0.1% | ▲New New position |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1889830/holdings"
Use Arkolith to show MIC Capital Management UK LLP's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 10, 2026 | 16 | $394.3M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | May 13, 2026 | 18 | $352.5M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 17, 2026 | 13 | $441.3M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 | 13 | $500.3M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 | 16 | $509.3M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 | 17 | $490.8M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 14, 2025 | 18 | $706.3M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 | 15 | $720.1M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.